ArticleFrontiers in medicine2026
Comparison of short-and long-term prognostic differences and validation of clinical prediction models between two types of mechanical thrombectomy in patients with acute ischemic stroke aged 75 years and above.
Article in Frontiers in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: As the global population ages, the incidence of acute ischemic stroke (AIS) among individuals aged 75 years and older is steadily increasing. Mechanical thrombectomy (MT) has become a standard treatment for AIS, with two commonly employed approaches: bridging thrombectomy (BT) and direct mechanical thrombectomy (DMT). However, the efficacy and safety of these strategies in elderly patients remain inconclusive. Methods: This single-center retrospective study included AIS patients aged 75 years and older who underwent BT or DMT at Liuan City Hospital of Traditional Chinese Medicine, affiliated with Anhui University of Traditional Chinese Medicine, between December 2020 and August 2024. After propensity score matching (PSM), patients were compared in terms of neurological outcomes (NIHSS, mRS), inflammatory markers (CRP, NLR, SII, SIRI), and complication rates at 24 h, 7 days, and 90 days post-treatment. A predictive model for 90-day functional outcome was developed using univariate and multivariate regression analyses and evaluated for performance. Results: A total of 87 patients were enrolled, and CRP levels on day 7 after treatment were significantly higher in the BT group than in the DMT group ( Conclusion: In AIS patients aged 75 years and older, both BT and DMT yielded comparable short- and long-term neurological outcomes. Onset Puncture Time, Postoperative NIHSS at 24 h and CRP at 7 days were key prognostic factors. The developed model may serve as a reliable tool for individualized prognosis assessment and optimization of treatment strategies in elderly stroke patients.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.